Skip to Content

금융 뉴스 허브

실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트

📈 강세장 분위기

BREAKING주요 뉴스

주식/증권 ➡️ 중립
05/21 16:30
YieldMax NFLX Option Income Strategy ETF announces weekly distribution of $0.0626

Seeking Alpha - Market News
주식/증권 ➡️ 중립
05/21 16:29
Accelerate Diversified Credit Income Fund Hedged ETF declares CAD 0.13 dividend

Seeking Alpha - Market News
주식/증권 ➡️ 중립
05/21 16:29
Accelerate Diversified Credit Income Fund ETF declares CAD 0.13 dividend

Seeking Alpha - Market News
주식/증권 📉 부정 🔴 매우 중요
05/21 16:28
US Equity Indexes Decline as Iran's Efforts to Keep Enriched Uranium Risk Fallout With Trump

US equity indexes fell, pressured by higher crude oil and Treasury yields, amid concern that Iran's

Yahoo Finance
주식/증권 ➡️ 중립
05/21 16:27
How does Lilly’s next-gen obesity drug compare to Novo’s

Seeking Alpha - Market News
주식/증권 ➡️ 중립
05/21 16:26
YieldMax MSTR Option Income Strategy ETF announces weekly distribution of $0.3136

Seeking Alpha - Market News
주식/증권 ➡️ 중립
05/21 16:24
YieldMax MSFT Option Income Strategy ETF announces weekly distribution of $0.0890

Seeking Alpha - Market News
주식/증권 ➡️ 중립 🔴 매우 중요
05/21 16:24
Stocks slide as oil jumps, investors assess Nvidia results

Seeking Alpha - Market News
주식/증권 ➡️ 중립
05/21 16:23
Here's Why You Should Retain OPK Stock in Your Portfolio for Now

OPKO Health leans on RAYALDEE and key partnerships, such as BioReference and 4Kscore, as it ramps toward mid-2026 diagnostics breakeven.

Yahoo Finance
주식/증권 ➡️ 중립
05/21 16:20
Nvidia’s Jensen Huang wants to be king of a brand-new empire

The chip maker is paving its way into a potential $200 billion market for central processing units.

MarketWatch - Top Stories
주식/증권 📈 긍정
05/21 16:18
SLF Stock Trades at 2.56X Book Value: What Should Investors Know?

Sun Life Financial expands in Asia and asset management while pursuing capital-light growth strategies to drive earnings and market positioning.

Yahoo Finance
주식/증권 ➡️ 중립
05/21 16:15
Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t.

Over the next year, countries that are home to 40% of the world’s population are set to get access to Ozempic and Wegovy generics that could cost as little as $15 a month.

MarketWatch - Top Stories